HBR: David Pyott Among Best Performing CEOs in the World











Canada's "national" newspaper, the Globe and Mail, does an annual analysis of Canadian corporate governance rankings called "Board Games". For the 2013 ranking, Valeant Pharmaceuticals came in the middle of the pack, #100 out of 232 Canadian companies. Valeant lost points for not splitting CEO and Chairman of the Board, for not including a significant number of women as board directors, and for not making full public disclosures on a variety of governance subjects.

(For the curious, a Canadian company that came in almost dead last --#229 out of 232 companies-- was CGI Group, the folks who brought you the rollout of the online application process for The Affordable Care Act last October.)